VideoHIVHIV DART and Emerging Viruses 2018HIV reservoir dynamics: Implications for HIV latency establishment and reversal | Deanna Kulpa, PhDView Video
VideoHIVHIV DART and Emerging Viruses 2018State of the Art Lecture: Molecular basis for HIV latency | Jonathan Karn, PhDView Video
VideoHIVHIV DART and Emerging Viruses 2018Understanding barriers to HIV cure | Robert Siliciano, MD, PhDView Video
VideoHIVHIV DART and Emerging Viruses 2018Baricitinib reverses HIV associated neurocognitive disorders and reservoir seeding in a SCID mouse model | Christina Gavegnano, PhDView Video
SDSteven DeeksMDVideoHIVHIV DART and Emerging Viruses 2018State of the Art Lecture: Harnessing the immune system to eliminate and/or control HIV | Steven Deeks, MDView Video
BCBonaventura ClotetMD, PhDVideoHIVHIV DART and Emerging Viruses 2018Barry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhDView Video
BCBonaventura ClotetMD, PhDSlidesetHIVHIV DART and Emerging Viruses 2018Barry-Wainberg DART Achievement Award Lecture: Overview of the research conducted at the Irsicaixa Foundation | Bonaventura Clotet, MD, PhDView Slideset
SlidesetHIV DART and Emerging Viruses 2018A post-transcriptional feedback mechanism for noise suppression and fate stabilization | Leor Weinberger, PhDView Slideset
SlidesetHIV DART and Emerging Viruses 2018Injectable ART: Advantages and disadvantages | Michael Saag, MDView Slideset
DHDaria HazudaPhDSlidesetHIV DART and Emerging Viruses 2018State of the Art Lecture: Rational design of doravirine (DOR): From bench to patients | Daria Hazuda, PhDView Slideset
CBCharles BoucherMD, PhDSlidesetHIV DART and Emerging Viruses 2018Presentation of Barry-Wainberg DART Achievement Award and recipient | Charles Boucher, MD, PhDView Slideset
SlidesetHIVHIV DART and Emerging Viruses 2018Abstract: Oral ABX464 has a dose dependent reduction in the HIV-1 DNA reservoir in CD4+ Peripheral Blood T Cells (#2) | Jean-Marc SteensView Slideset
